Current status and future prospects of proton MR spectroscopy of the breast with a 1.5T MR unit

Journal of Oncology

Volumn , Issue , 2010, Pages

  Tozaki, Mitsuhiro ^a   Maruyama, Katsuya ^b  

^a KAMEDA MEDICAL CENTER   (Japan)

^b Siemens Healthcare KK   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CONTRAST MEDIUM; GLYCEROPHOSPHORYLCHOLINE; INOSITOL; PHOSPHORYLCHOLINE; TAURINE; TUMOR MARKER;

ADJUVANT CHEMOTHERAPY; BREAST CANCER; BREAST DISEASE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; METABOLITE; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; THERAPY EFFECT;

EID: 78349287353     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2010/781621     Document Type: Review

References (44)

1. ACR Practice guideline for the performance of contrast-enhanced magnetic resonance imaging (MRI) of the breast, www.acr.org/SecondaryMainMenuCategories/ qualitysafety/guidelines/breast.aspx
2. Mann R. M., Kuhl C. K., Kinkel K., Boetes C., Breast MRI: guidelines from the European Society of Breast Imaging European Radiology 2008 18 7 1307 1318
3. Glunde K., Jie C., Bhujwalla Z. M., Molecalar causes of tile aberrant choline phospholipid metabolism in breast cancer Cancer Research 2004 64 12 4270 4276
4. Stanwell P., Gluch L., Clark D., Tomanek B., Baker L., Giuffr B., Lean C., Malycha P., Mountford C., Specificity of choline metabolites for in vivo diagnosis of breast cancer using 1H MRS at 1.5 T European Radiology 2005 15 5 1037 1043
5. Kvistad K. A., Bakken I. J., Gribbestad I. S., Ehrnholm B., Lundgren S., Fjsne H. E., Haraldseth O., Characterization of neoplastic and normal human breast tissues with in vivo 1H MR spectroscopy Journal of Magnetic Resonance Imaging 1999 10 2 159 164
6. Tozaki M., Proton MR spectroscopy of the breast Breast Cancer 2008 15 3 218 223
7. Bottomley P. A., On restoring motion-induced signal loss in single-voxel magnetic resonance spectra Magnetic Resonance in Medicine 1987 508 333 348
8. Stanwell P., Mountford C., In vivo proton MR spectroscopy of the breast Radiographics 2007 27 S253 S266
9. Star-Lack J., Nelson S. J., Kurhanewicz J., Huang L. R., Vigneron D. B., Improved water and lipid suppression for 3D PRESS CSI using RF band selective inversion with gradient dephasing (BASING) Magnetic Resonance in Medicine 1997 38 2 311 321
10. Haase A., Frahm J., Hanicke W., Matthaei D., 1H NMR chemical shift selective (CHESS) imaging Plasma Sources Science and Technology 1985 30 4 341 344
11. Bolan P. J., Meisamy S., Baker E. H., Lin J., Emory T., Nelson M., Everson L. I., Yee D., Garwood M., In vivo quantification of choline compounds in the breast with 1H MR spectroscopy Magnetic Resonance in Medicine 2003 50 6 1134 1143
12. Bakken I. J., Gribbestad I. S., Singstad T. E., Kvistad K. A., External standard method for the in vivo quantification of choline-containing compounds in breast tumors by proton MR spectroscopy at 1.5 Tesla Magnetic Resonance in Medicine 2001 46 1 189 192
13. Baek H.-M., Chen J.-H., Nie K., Yu H. J., Bahri S., Mehta R. S., Nalcioglu O., Su M.-Y., Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy Radiology 2009 251 3 653 662
14. Baik H.-M., Su M.-Y., Yu H., Nalcioglu O., Mehta R., Quantification of choline-containing compounds in malignant breast tumors by 1H MR spectroscopy using water as an internal reference at 1.5 T Magnetic Resonance Materials in Physics, Biology and Medicine 2006 19 2 96 104
15. Huang W., Fisher P. R., Dulaimy K., Tudorica L. A., O'Hea B., Button T. M., Detection of breast malignancy: diagnostic MR protocol for improved specificity Radiology 2004 232 2 585 591
16. Bartella L., Morris E. A., Dershaw D. D., Liberman L., Thakur S. B., Moskowitz C., Guido J., Huang W., Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study Radiology 2006 239 3 686 692
17. Roebuck J. R., Cecil K. M., Schnall M. D., Lenkinski R. E., Human breast lesions: characterization with proton MR spectroscopy Radiology 1998 209 1 269 275
18. Cecil K. M., Schnall M. D., Siegelman E. S., Lenkinski R. E., The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy Breast Cancer Research and Treatment 2001 68 1 45 54
19. Yeung D. K. W., Cheung H. S., Tse G. M. K., Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopyinitial results Radiology 2001 220 1 40 46
20. Jagannathan N. R., Kumar M., Seenu V., Coshic O., Dwivedi S. N., Julka P. K., Srivastava A., Rath G. K., Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer British Journal of Cancer 2001 84 8 1016 1022
21. Tse G. M. K., Cheung H. S., Pang L.-M., Chu W. C. W., Law B. K. B., Kung F. Y. L., Yeung D. K. W., Characterization of lesions of the breast with proton MR spectroscopy: comparison of carcinomas, benign lesions, and phyllodes tumors American Journal of Roentgenology 2003 181 5 1267 1272
22. Sardanelli F., Fausto A., Di Leo G., De Nijs R., Vorbuchner M., Podo F., In vivo proton MR spectroscopy of the breast using the total choline peak integral as a marker of malignancy American Journal of Roentgenology 2009 192 6 1608 1617
23. Tozaki M., Fukuma E., 1H MR spectroscopy and diffusion-weighted imaging of the breast: are they useful tools for characterizing breast lesions before biopsy? American Journal of Roentgenology 2009 193 3 840 849
24. American College of Radiology, Breast Imaging Reporting and Data System (BI-RADS) 2003 4th Reston, Va, USA American College of Radiology
25. Bartella L., Thakur S. B., Morris E. A., Dershaw D. D., Huang W., Chough E., Cruz M. C., Liberman L., Enhancing nonmass lesions in the breast: evaluation with proton (1H) MR spectroscopy Radiology 2007 245 1 80 87
26. Baek H.-M., Chen J.-H., Yu H. J., Mehta R., Nalcioglu O., Su M.-Y., Detection of choline signal in human breast lesions with chemical-shift imaging Journal of Magnetic Resonance Imaging 2008 27 5 1114 1121
27. Lenkinski R. E., Wang X., Elian M., Goldberg S. N., Interaction of gadolinium-based MR contrast agents with choline: implications for MR spectroscopy (MRS) of the breast Magnetic Resonance in Medicine 2009 61 6 1286 1292
28. Lean C., Doran S., Somorjai R. L., Malycha P., Clarke D., Himmelreich U., Bourne R., Dolenko B., Nikulin A. E., Mountford C., Determination of grade and receptor status from the primary breast lesion by magnetic resonance spectroscopy Technology in Cancer Research and Treatment 2004 3 6 551 556
29. Tozaki M., Hoshi K., 1H MR spectroscopy of invasive ductal carcinoma: correlations with FDG PET and histological prognostic factors American Journal of Roentgenology 2010 194 1384 1390
30. Tozaki M., Kobayashi T., Uno S., Aiba K., Takeyama H., Shioya H., Tabei I., Toriumi Y., Suzuki M., Fukuda K., Breast-conserving surgery after chemotherapy: value of MDCT for determining tumor distribution and shrinkage pattern American Journal of Roentgenology 2006 186 2 431 439
31. Weatherall P. T., Evans G. F., Metzger G. J., Saborrian M. H., Leitch A. M., MRI vs. histologic measurement of breast cancer following chemotherapy: comparison with x-ray mammography and palpation Journal of Magnetic Resonance Imaging 2001 13 6 868 875
32. Partridge S. C., Gibbs J. E., Lu Y., Esserman L. J., Sudilovsky D., Hylton N. M., Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy American Journal of Roentgenology 2002 179 5 1193 1199
33. Yeh E., Slanetz P., Kopans D. B., Rafferty E., Georgian-Smith D., Moy L., Halpern E., Moore R., Kuter I., Taghian A., Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer American Journal of Roentgenology 2005 184 3 868 877
34. Tardivon A. A., Ollivier L., Khoury C., Thibault F., Monitoring therapeutic efficacy in breast carcinomas European Radiology 2006 16 11 2549 2558
35. Jagannathan N. R., Kumar M., Seenu V., Coshic O., Dwivedi S. N., Julka P. K., Srivastava A., Rath G. K., Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer British Journal of Cancer 2001 84 8 1016 1022
36. Meisamy S., Bolan P. J., Baker E. H., Bliss R. L., Gulbahce E., Everson L. I., Nelson M. T., Emory T. H., Tuttle T. M., Yee D., Garwood M., Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo 1H MR spectroscopya pilot study at 4 T Radiology 2004 233 2 424 431
37. Kumar M., Jagannathan N. R., Seenu V., Dwivedi S. N., Julka P. K., Rath G. K., Monitoring the therapeutic response of locally advanced breast cancer patients: sequential in vivo proton MR spectroscopy study Journal of Magnetic Resonance Imaging 2006 24 2 325 332
38. Manton D. J., Chaturvedi A., Hubbard A., Lind M. J., Lowry M., Maraveyas A., Pickles M. D., Tozer D. J., Turnbull L. W., Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy British Journal of Cancer 2006 94 3 427 435
39. Tozaki M., Sakamoto M., Oyama Y., O'uchi T., Kawano N., Suzuki T., Yamashiro N., Ozaki S., Sakamoto N., Higa K., Abe S., Ogawa T., Fukuma E., Monitoring of early response to neoadjuvant chemotherapy in breast cancer with 1H MR spectroscopy: comparison to sequential 2-[18F]-fluorodeoxyglucose positron emission tomography Journal of Magnetic Resonance Imaging 2008 28 2 420 427
40. Baek H.-M., Chen J.-H., Nie K., Yu H. J., Bahri S., Mehta R. S., Nalcioglu O., Su M.-Y., Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy Radiology 2009 251 3 653 662
41. Tozaki M., What is best for early response to chemotherapy: size, curve, diffusion, spectroscopy, PET? European Radiology 2009 19 S944 S946
42. Tozaki M., Oyama Y., Fukuma E., Preliminary study of early response to neoadjuvant chemotherapy after the first cycle in breast cancer: comparison of 1H MR spectroscopy with diffusion MR imaging Japanese Journal of Radiology 2010 28 101 109
43. Tozaki M., Sakamoto M., Oyama Y., Maruyama K., Fukuma E., Predicting pathological response to neoadjuvant chemotherapy in breast cancer with quantitative 1H MR spectroscopy using the external standard method Journal of Magnetic Resonance Imaging 2010 31 895 902
44. Rousseau C., Devillers A., Sagan C., Ferrer L., Bridji B., Campion L., Ricaud M., Bourbouloux E., Doutriaux I., Clouet M., Berton-Rigaud D., Bouriel C., Delecroix V., Garin E., Rouquette S., Resche I., Kerbrat P., Chatal J. F., Campone M., Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography Journal of Clinical Oncology 2006 24 34 5366 5372